U.S. markets open in 5 hours 37 minutes
  • S&P Futures

    4,447.00
    -15.50 (-0.35%)
     
  • Dow Futures

    35,078.00
    -93.00 (-0.26%)
     
  • Nasdaq Futures

    15,058.75
    -75.75 (-0.50%)
     
  • Russell 2000 Futures

    2,252.80
    -12.20 (-0.54%)
     
  • Crude Oil

    83.05
    +0.77 (+0.94%)
     
  • Gold

    1,765.20
    -3.10 (-0.18%)
     
  • Silver

    23.33
    -0.02 (-0.08%)
     
  • EUR/USD

    1.1592
    -0.0009 (-0.08%)
     
  • 10-Yr Bond

    1.5760
    +0.0570 (+3.75%)
     
  • Vix

    17.45
    +0.59 (+3.50%)
     
  • GBP/USD

    1.3742
    +0.0065 (+0.48%)
     
  • USD/JPY

    114.2760
    +0.5990 (+0.53%)
     
  • BTC-USD

    62,148.73
    +1,636.36 (+2.70%)
     
  • CMC Crypto 200

    1,454.32
    +47.58 (+3.38%)
     
  • FTSE 100

    7,219.31
    -14.72 (-0.20%)
     
  • Nikkei 225

    29,025.46
    +474.56 (+1.66%)
     

SHAREHOLDER ALERT: WeissLaw LLP Investigates Chiasma, Inc.

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, May 5, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Chiasma, Inc. ("Chiasma" or the "Company") (NASDAQ: CHMA) in connection with the proposed acquisition of the Company by Amryt Pharma plc ("Amryt") (NASDAQ: AMYT). Under the terms of the merger agreement, Chiasma stockholders will receive 0.396 Amryt American Depositary Shares ("ADSs"), each representing five Amryt ordinary shares, for each Chiasma share that they own, representing implied consideration of $5.13 based upon Amryt's ADS's May 4, 2021 closing price of $12.95. At closing, Chiasma's current stockholders will only own a 40% stake in the combined company.

WeissLaw LLP (PRNewsfoto/WeissLaw LLP)
WeissLaw LLP (PRNewsfoto/WeissLaw LLP)

If you own Chiasma shares and wish to discuss this investigation or have any questions concerning this notice or your rights or interests, visit our website:

http://www.weisslawllp.com/CHMA/

Or please contact:
Joshua Rubin, Esq.
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY 10036
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com

WeissLaw LLP is investigating whether Chiasma's board acted in the best interest of Chiasma's stockholders in agreeing to the proposed transaction, whether the exchange ratio is fair to the Company's stockholders and whether all information regarding the process undertaken by the board and the valuation of the transaction will be fully and fairly disclosed to Chiasma's stockholders.

WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at stockinfo@weisslawllp.com

Cision
Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-investigates-chiasma-inc-301285005.html

SOURCE WeissLaw LLP